Coon A - Search Results

1

Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase.

Kim YH, Coon A, Baker AF, Powis G. Kim YH, et al. Among authors: coon a. Cancer Chemother Pharmacol. 2011 Aug;68(2):405-13. doi: 10.1007/s00280-010-1500-0. Epub 2010 Nov 11. Cancer Chemother Pharmacol. 2011. PMID: 21069338 Free PMC article.

2

The antitumor agent imexon activates antioxidant gene expression: evidence for an oxidative stress response.

Baker AF, Landowski T, Dorr R, Tate WR, Gard JM, Tavenner BE, Dragovich T, Coon A, Powis G. Baker AF, et al. Among authors: coon a. Clin Cancer Res. 2007 Jun 1;13(11):3388-94. doi: 10.1158/1078-0432.CCR-06-0873. Clin Cancer Res. 2007. PMID: 17545547 Free PMC article.

3

In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316.

Meuillet EJ, Ihle N, Baker AF, Gard JM, Stamper C, Williams R, Coon A, Mahadevan D, George BL, Kirkpatrick L, Powis G. Meuillet EJ, et al. Among authors: coon a. Oncol Res. 2004;14(10):513-27. doi: 10.3727/0965040042380487. Oncol Res. 2004. PMID: 15559765

4

The role of the redox protein thioredoxin in cell growth and cancer.

Powis G, Mustacich D, Coon A. Powis G, et al. Among authors: coon a. Free Radic Biol Med. 2000 Aug;29(3-4):312-22. doi: 10.1016/s0891-5849(00)00313-0. Free Radic Biol Med. 2000. PMID: 11035260 Review.

5

Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity.

Meuillet EJ, Mahadevan D, Berggren M, Coon A, Powis G. Meuillet EJ, et al. Among authors: coon a. Arch Biochem Biophys. 2004 Sep 15;429(2):123-33. doi: 10.1016/j.abb.2004.04.020. Arch Biochem Biophys. 2004. PMID: 15313215

6

Specific inhibition of the Akt1 pleckstrin homology domain by D-3-deoxy-phosphatidyl-myo-inositol analogues.

Meuillet EJ, Mahadevan D, Vankayalapati H, Berggren M, Williams R, Coon A, Kozikowski AP, Powis G. Meuillet EJ, et al. Among authors: coon a. Mol Cancer Ther. 2003 Apr;2(4):389-99. Mol Cancer Ther. 2003. PMID: 12700283

7

Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells.

Dvorakova K, Payne CM, Tome ME, Briehl MM, Vasquez MA, Waltmire CN, Coon A, Dorr RT. Dvorakova K, et al. Among authors: coon a. Mol Cancer Ther. 2002 Jan;1(3):185-95. Mol Cancer Ther. 2002. PMID: 12467213

8

Mitomycin C inhibits ribosomal RNA: a novel cytotoxic mechanism for bioreductive drugs.

Snodgrass RG, Collier AC, Coon AE, Pritsos CA. Snodgrass RG, et al. Among authors: coon ae. J Biol Chem. 2010 Jun 18;285(25):19068-75. doi: 10.1074/jbc.M109.040477. Epub 2010 Apr 23. J Biol Chem. 2010. PMID: 20418373 Free PMC article.

9

Flow diversion of cerebral aneurysms in Type I osteogenesis imperfecta: A case report of the first two treatments in humans.

Zarrin DA, Campos JK, Meyer BM, Himstead AS, Laghari F, Collard de Beaufort JC, Golshani K, Beaty NB, Bender MT, Colby GP, Coon AL. Zarrin DA, et al. Among authors: coon al. SAGE Open Med Case Rep. 2024 Aug 24;12:2050313X241274243. doi: 10.1177/2050313X241274243. eCollection 2024. SAGE Open Med Case Rep. 2024. PMID: 39185069 Free PMC article.

10

First-in-Human Percutaneous Use of a Cerebral Flow-Diverting Stent in a Large Coronary Aneurysm.

Patel CP, Coon AL. Patel CP, et al. Among authors: coon al. J Soc Cardiovasc Angiogr Interv. 2024 Mar 6;3(4):101232. doi: 10.1016/j.jscai.2023.101232. eCollection 2024 Apr. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39130171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters